Please Note:
This profile was automatically generated using 3 references found on the Internet. This information has not been verified. Learn more...

Employment History

View...

 Web References

  1. 1. NASADAD -- NIAAA Research Findings
    www.nasadad.org/index.php?doc_ - [Cached]

    Published on: 8/31/2001   Last Visited: 12/11/2007

    Panel Members: Arthur Evans (CT), Maria Canfield (NV), Ray Stephens (AR)
    ...
    Ken Stark introduced the panel members Arthur Evans (CT), Maria Canfield (NV), and Ray Stephens (AR).
    ...
    Arthur Evans noted his experience both as a clinician and as an administrator in describing the obstacles to the integration of Naltrexone with the treatment system. The Connecticut system uses a managed care model and is currently focusing on measuring and improving continuity of care, readmission and access. An analysis of the data they are developing indicates that a key issue is implementation of system-wide procedures that improve access to appropriate treatment. Mr. Evans noted the need to move from identifying barriers to identifying cost-effective procedures for using naltrexone in a system that is not set up to use medication.
  2. 2. www.nasadad.org
    www.nasadad.org/index.php?wv_e - [Cached]

    Published on: 8/31/2001   Last Visited: 3/10/2007

    Panel Members: Arthur Evans (CT), Maria Canfield (NV), Ray Stephens (AR)
    ...
    Ken Stark introduced the panel members Arthur Evans (CT), Maria Canfield (NV), and Ray Stephens (AR).
    ...
    Arthur Evans noted his experience both as a clinician and as an administrator in describing the obstacles to the integration of Naltrexone with the treatment system. The Connecticut system uses a managed care model and is currently focusing on measuring and improving continuity of care, readmission and access. An analysis of the data they are developing indicates that a key issue is implementation of system-wide procedures that improve access to appropriate treatment. Mr. Evans noted the need to move from identifying barriers to identifying cost-effective procedures for using naltrexone in a system that is not set up to use medication.
  3. 3. www.nasadad.org
    www.nasadad.org/index.php?base - [Cached]

    Published on: 8/31/2001   Last Visited: 3/10/2007

    Panel Members: Arthur Evans (CT), Maria Canfield (NV), Ray Stephens (AR)
    ...
    Ken Stark introduced the panel members Arthur Evans (CT), Maria Canfield (NV), and Ray Stephens (AR).
    ...
    Arthur Evans noted his experience both as a clinician and as an administrator in describing the obstacles to the integration of Naltrexone with the treatment system. The Connecticut system uses a managed care model and is currently focusing on measuring and improving continuity of care, readmission and access. An analysis of the data they are developing indicates that a key issue is implementation of system-wide procedures that improve access to appropriate treatment. Mr. Evans noted the need to move from identifying barriers to identifying cost-effective procedures for using naltrexone in a system that is not set up to use medication.

Recent Updates
People Updates  5-18-2008,   People Updates  5-17-2008,   People Updates  5-16-2008,   People Updates  5-15-2008,   People Updates  5-14-2008,   People Updates  5-13-2008,   People Updates  5-12-2008,   Recent People Updates
Recent Company Updates
Company Directory
Medical Devices & Equipment , Insurance , Software Development & Design ...